Author

Govinda R Hancock

Loyola University ChicagoORCID 0000-0002-3384-7983Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Kristen S. YoungiD· 2 shared Sean William FanningiD· 2 shared Steven KregeliD· 2 shared Abhishek Solanki· 1 shared Alexandra Zigrossi· 1 shared Audris BudreikaiD· 1 shared Austin P RundeiD· 1 shared Brenna FlowersiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kristen S. YoungORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator that promotes prostate cancer proliferation.

Raymond J. Kostlan, John T. Phoenix, Audris Budreika, Carli D. Deegan, Marina G. Ferrari, Elise T Warren, Pushpinder Bawa, Charles S Rogers, Divya Dureja, M Obaidulla Ibne Ali, Govinda R Hancock, Kristen S. Young, Gopal Gupta, Abhishek Solanki, Donald J. Vander Griend, , Steven Kregel

This study identifies METTL3 as a non-enzymatic AR co-regulator that promotes prostate cancer proliferation by supporting AR-driven transcriptional programs.

bioRxiv · Jul 9, 2026 · PreprintCancer Biology

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells

Kristen S. Young, Govinda R Hancock, Emma C. Fink, Alexandra Zigrossi, Brenna Flowers, D. A. Cooper, Vy T. Nguyen, Millie Martinez, Khin Su Mon, Maarten C. Bosland, Donald R. Zak, Austin P Runde, Marina Nasrin Sharifi, Irida Kastrati, David D. L. Minh, , Sean William Fanning

This study investigates how a novel SERM, T6I-29, downregulates DKK1 in Y537S ESR1 mutant breast cancer cells and identifies DKK1 as a potential therapeutic target.

Breast Cancer Research · Jan 17, 2025Peer-reviewedCancer Biology